Molecular characterization of central neurocytomas: Potential markers for tumor typing and progression

Neuropathology

Volumn 33, Issue 2, 2013, Pages 149-161

  Vasiljevic, Alexandre ^a   Champier, Jacques ^b   Figarella Branger, Dominique ^d,e   Wierinckx, Anne ^c   Jouvet, Anne ^a,b   Fèvre Montange, Michelle ^b  

^a Groupement Hospitalier Est ^*  (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c UNIVERSITÉ DE LYON   (France)

^d TIMONE HOSPITAL   (France)

^e University of the Mediterranean Aix Marseille II   (France)

Author keywords

Central neurocytoma; Microarray; Pineal parenchymal tumor; Pineocytoma

Indexed keywords

BETA CATENIN; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOLECULAR TYPING; NERVE CELL DIFFERENTIATION; NEUROEPITHELIOMA; NUCLEOTIDE SEQUENCE; PINEAL BODY TUMOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STUDY; TRANSCRIPTOMICS; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROCYTOMA; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84875805677     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01338.x     Document Type: Article

References (69)

1. Hassoun J, Gambarelli D, Grisoli F etal. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 1982; 56: 151-156.
2. Schmidt MH, Gottfried ON, Von Koch CS, Chang SM, McDermott MW. Central neurocytoma: a review. J Neurooncol 2004; 66: 377-384.
3. Figarella-Branger D, Soylemezoglu F, Burger PC. Central neurocytoma and extraventricular neurocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, Lyon: International Agency for Research on Cancer, 2007; 106-109.
4. Yin XL, Pang JC, Hui AB, Ng HK. Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. J Neurosurg 2000; 93: 77-81.
5. Korshunov A, Sycheva R, Golanov A. Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance. Acta Neuropathol 2007; 113: 303-312.
6. Kane AJ, Sughrue ME, Rutkowski MJ, Tihan T, Parsa AT. The molecular pathology of central neurocytomas. J Clin Neurosci 2011; 18: 1-6.
7. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 2006; 1: 581-585.
8. Fevre-Montange M, Champier J, Durand A etal. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 2009; 35: 1395-1407.
9. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
10. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
11. Sim FJ, Keyoung HM, Goldman JE etal. Neurocytoma is a tumor of adult neuronal progenitor cells. J Neurosci 2006; 26: 12544-12555.
12. Ljubimova JY, Khazenzon NM, Chen Z etal. Gene expression abnormalities in human glial tumors identified by gene array. Int J Oncol 2001; 18: 287-295.
13. Boon K, Edwards JB, Siu IM etal. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene 2003; 22: 7687-7694.
14. Kavsan VM, Dmitrenko VV, Shostak KO etal. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma. Tsitol Genet 2007; 41: 36-55.
15. Hartmann W, Koch A, Brune H etal. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am J Pathol 2005; 166: 1153-1162.
16. Uysal-Onganer P, Kawano Y, Caro M etal. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer 2010; 9: 55.
17. Miyakoshi T, Takei M, Kajiya H etal. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Endocr Pathol 2008; 19: 261-273.
18. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 2009; 55: 307-317.
19. Ghzili H, Grumolato L, Thouennon E etal. Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol 2008; 29: 128-141.
20. Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. BMC Cancer 2010; 10: 676.
21. Nagase H, Agren J, Saito A etal. Molecular cloning and characterization of mouse aquaporin 6. Biochem Biophys Res Commun 2007; 352: 12-16.
22. Rabaud NE, Song L, Wang Y, Agre P, Yasui M, Carbrey JM. Aquaporin 6 binds calmodulin in a calcium-dependent manner. Biochem Biophys Res Commun 2009; 383: 54-57.
23. Whitford KL, Marillat V, Stein E etal. Regulation of cortical dendrite development by Slit-Robo interactions. Neuron 2002; 33: 47-61.
24. Rossi MR, Huntoon K, Cowell JK. Differential expression of the LGI and SLIT families of genes in human cancer cells. Gene 2005; 356: 85-90.
25. Hu S, Zhang M, Lv Z, Bi J, Dong Y, Wen J. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Neoplasma 2007; 54: 207-211.
26. Wu C, Qiu R, Wang J, Zhang H, Murai K, Lu Q. ZHX2 Interacts with Ephrin-B and regulates neural progenitor maintenance in the developing cerebral cortex. J Neurosci 2009; 29: 7404-7412.
27. Wu I, Moses MA. BNF-1, a novel gene encoding a putative extracellular matrix protein, is overexpressed in tumor tissues. Gene 2003; 311: 105-110.
28. De Robertis EM, Larrain J, Oelgeschlager M, Wessely O. The establishment of Spemann's organizer and patterning of the vertebrate embryo. Nat Rev Genet 2000; 1: 171-181.
29. Bruzzone F, Lectez B, Alexandre D etal. Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. J Comp Neurol 2007; 503: 573-591.
30. Doglioni C, Dei Tos AP, Laurino L etal. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20: 1037-1046.
31. Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol 2011; 35: 1786-1793.
32. Mustain WC, Rychahou PG, Evers BM. The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes 2011; 18: 75-82.
33. Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006; 27: 2424-2433.
34. Rodriguez Y, Almeida TA, Valladares F etal. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas. Biol Reprod 2010; 83: 641-647.
35. Giorgi RR, Chile T, Bello AR, Reyes R etal. Expression of neurotensin and its receptors in pituitary adenomas. J Neuroendocrinol 2008; 20: 1052-1057.
36. Ishikawa N, Daigo Y, Takano A etal. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer. Cancer Sci 2006; 97: 737-745.
37. Shi BZ, Hu P, Geng F, He PJ, Wu XZ. Gal3ST-2 involved in tumor metastasis process by regulation of adhesion ability to selectins and expression of integrins. Biochem Biophys Res Commun 2005; 332: 934-940.
38. Na K, Lee EY, Lee HJ etal. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 2009; 9: 3989-3999.
39. Massalini S, Pellegatta S, Pisati F, Finocchiaro G, Farace MG, Ciafre SA. Reelin affects chain-migration and differentiation of neural precursor cells. Mol Cell Neurosci 2009; 42: 341-349.
40. Feng L, Hatten ME, Heintz N. Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 1994; 12: 895-908.
41. Liu RZ, Mita R, Beaulieu M, Godbout R. Fatty acid binding proteins in brain development and disease. Int J Dev Biol 2010; 54: 1229-1239.
42. Godbout R, Bisgrove DA, Shkolny D, Day RS. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998; 16: 1955-1962.
43. Kristensen MH, Nielsen S, Vyberg M. Thyroid transcription factor-1 in primary CNS tumors. Appl Immunohistochem Mol Morphol 2011; 19: 437-443.
44. Begley CG, Lipkowitz S, Gobel V etal. Molecular characterization of NSCL, a gene encoding a helix-loop-helix protein expressed in the developing nervous system. Proc Natl Acad Sci U S A 1992; 89: 38-42.
45. Bao J, Talmage DA, Role LW, Gautier J. Regulation of neurogenesis by interactions between HEN1 and neuronal LMO proteins. Development 2000; 127: 425-435.
46. Yuan SH, Qiu Z, Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 2009; 106: 2909-2914.
47. Cheung M, Abu-Elmagd M, Clevers H, Scotting PJ. Roles of Sox4 in central nervous system development. Brain Res Mol Brain Res 2000; 79: 180-191.
48. de Bont JM, Kros JM, Passier MM etal. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 2008; 10: 648-660.
49. Lin B, Madan A, Yoon JG etal. Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS ONE 2010; 5: e10210.
50. Fevre-Montange M, Champier J, Szathmari A etal. Microarray analysis reveals differential gene expression patterns in tumors of the pineal region. J Neuropathol Exp Neurol 2006; 65: 675-684.
51. Liu T, Bohlken A, Kuljaca S etal. The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer 2005; 93: 310-318.
52. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411-414.
53. Lan MS, Breslin MB. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 2009; 23: 2024-2033.
54. Ohsawa R, Ohtsuka T, Kageyama R. Mash1 and Math3 are required for development of branchiomotor neurons and maintenance of neural progenitors. J Neurosci 2005; 25: 5857-5865.
55. Martinez-Fuentes AJ, Molina M, Vazquez-Martinez R etal. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol 2011; 164: 355-362.
56. Schmid K, Wang X, Haitel A etal. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 2007; 450: 143-149.
57. Wagner KW, Sapinoso LM, El-Rifai W etal. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004; 23: 6621-6629.
58. Carvalho LH, Smirnov I, Baia GS, etal. Molecular signatures define two main classes of meningiomas. Mol Cancer 2007; 6: 64.
59. Ito T, Shimada Y, Kan T, etal. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 3214-3224.
60. Liao LJ, Hsu YH, Yu CH etal. Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions. Head Neck 2011; 33: 719-726.
61. Liang M, Chen X, Liu W etal. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma. Cancer Biol Ther 2011; 11: 337-345.
62. Chae YK, Kang SK, Kim MS etal. Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). PLoS ONE 2008; 3: e2594.
63. Kang SK, Chae YK, Woo J etal. Role of human aquaporin 5 in colorectal carcinogenesis. Am J Pathol 2008; 173: 518-525.
64. Zhang Z, Chen Z, Song Y, Zhang P, Hu J, Bai C. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer. J Pathol 2010; 221: 210-220.
65. Ueno K, Hazama S, Mitomori S etal. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer 2009; 101: 1374-1381.
66. Zeng WF, Navaratne K, Prayson RA, Weil RJ. Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme. J Clin Pathol 2007; 60: 218-221.
67. Le Calve B, Rynkowski M, Le Mercier M etal. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia 2010; 12: 727-739.
68. Dong Z, Wang X, Evers BM. Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1139-G1147.
69. Kawamoto T, Ohira M, Hamano S, Hori T, Nakagawara A. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas. Int J Oncol 2003; 22: 815-822.